Skip to content

Daclatasvir Impurity G

Daclatasvir Impurity G

Product Description
CAT No.
ALN-D036032
CAS No.
NA
Mol. F.
C40H49N7O7
Mol. Wt.
739.9
Stock
Please Inquire
RFQ
Chemical Name : Methyl ((S)-1-((S)-2-(4-(4′-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-4-yl)-[1,1′-biphenyl]-4-yl)oxazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate
Smiles : O=C(OC)N[C@@H](C(C)C)C(N1[C@H](C2=NC(C3=CC=C(C4=CC=C(C5=CNC([C@H]6N(C([C@@H](NC(OC)=O)C(C)C)=O)CCC6)=N5)C=C4)C=C3)=CO2)CCC1)=O
Inchi : InChI=1S/C23H25NO5/c1-16(23(28)29-2)14-20(24-21(25)12-13-22(26)27)15-17-8-10-19(11-9-17)18-6-4-3-5-7-18/h3-13,16,20H,14-15H2,1-2H3,(H,24,25)(H,26,27)/b13-12+/t16-,20+/m1/s1

A validated stability-indicating reverse-phase high-performance liquid chromatography method for daclatasvir, identification and characterization of degradation products using LC-ESI-QTOF-MS

By Warghade, Snehal V.; Bothara, Kailash G.nFrom Asian Journal of Pharmaceutical and Clinical Research (2019), 12(5), 302-308

Development and validation of HPLC fluorescence and UPLC/DAD stability-indicating methods for determination of hepatitis C antiviral agent daclatasvir

By Kamal, Andra H.; Ismail, Nahla S.; Mabroijk, Mokhtar M.; Bebawy, Lories I.; Mekky, Mai A. – From Journal of AOAC International (2019), 102(4), 1125-1131

A stability-indicating UPLC method for the determination of potential impurities and its mass by a new QDa mass detector in daclatasvir drug used to treat hepatitis C infection

By Jagadabi, Varaprasad; Kumar, P. V. Nagendra; Mahesh, Kasthuri; Pamidi, Srinivasu; Ramaprasad, L. A.; Nagaraju, D. – From Journal of Chromatographic Science (2019), 57(1), 44-53

Request For Quotation

Related Products